More on TSHA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-44.4% Growth)
- Ratings (9.0 Score)

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Taysha Gene Therapies (NQ:TSHA)
Delayed: 3.96 -0.05 (1.25%)
Prev. Close $4.01  
Open$3.95 
52 Wk High$ 
52 Wk Low$ 
Day High$3.98 
Day Low$3.76 
P/E N/A  
EPS$ 
Volume2,592,943 

Friends, Peers and Foes (?): NGNE (more...)

Oct 2, 2026 08:00 AM Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Oct 1, 2026 08:00 AM Taysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting
Sep 17, 2026 05:03 AM Wolfe Research Starts Taysha Gene Therapies (TSHA) at Outperform
Sep 4, 2026 08:00 AM Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Aug 14, 2026 04:50 PM Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 13, 2026 05:38 PM Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: MORGAN STANLEY
Aug 11, 2026 04:19 PM Taysha Gene Therapies (TSHA) Misses Q2 EPS by 1c
Aug 11, 2026 04:08 PM Form 10-Q Taysha Gene Therapies, For: Jun 30
Aug 11, 2026 04:06 PM Form 8-K Taysha Gene Therapies, For: Aug 11
Aug 11, 2026 04:00 PM Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
View All Articles

Entities mentioned with TSHA

View All Entities